DJ
Dupont Jakob Vice-Président Exécutif, Responsable de la R&D
Other M
US US · SEC (Form 4)
Browse the full record of transactions filed by Dupont Jakob, Vice-Président Exécutif, Responsable de la R&D. Insider active across 2 companies, notably Atara Biotherapeutics, Inc.. In total, 15 reports have been published. Total volume traded: €255k. The latest transaction was filed on 17 May 2022 — Cession. Regulator: SEC (Form 4). The full history is free.
Declarations 15 total
€19,527 3,873 shares @ €5.0418 0.024% mcap 5.3% of flow
Common Stock
SEC:0001140361-22-019981:0 · 17 May 2022
078,506 shares 0
Common Stock
SEC:0001140361-22-007765:0 · 1 Mar 2022
€41,938 5,000 shares @ €8.3877 0.051% mcap 11.4% of flow
Common Stock
SEC:0001567619-22-004499:0 · 10 Feb 2022
€42,116 5,000 shares @ €8.4231 0.032% mcap 23.2% of flow
Common Stock
SEC:0001567619-22-000568 · 3 Jan 2022
€42,116 5,000 shares @ €8.4231 0.052% mcap 11.5% of flow
Common Stock
SEC:0001567619-22-000568:0 · 3 Jan 2022
€42,276 5,000 shares @ €8.4552 0.032% mcap 23.3% of flow
Common Stock
SEC:0001567619-21-021583 · 1 Dec 2021
€42,276 5,000 shares @ €8.4552 0.052% mcap 11.5% of flow
Common Stock
SEC:0001567619-21-021583:0 · 1 Dec 2021
€33,115 2,199 shares @ €15.0591 0.025% mcap 18.2% of flow
Common Stock
SEC:0001567619-21-020777 · 16 Nov 2021
€33,115 2,199 shares @ €15.0591 0.041% mcap 9.0% of flow
Common Stock
SEC:0001567619-21-020777:0 · 16 Nov 2021
€41,295 5,000 shares @ €8.2589 0.031% mcap 22.7% of flow
Common Stock
SEC:0001567619-21-019331 · 2 Nov 2021
€41,295 5,000 shares @ €8.2589 0.051% mcap 11.3% of flow
Common Stock
SEC:0001567619-21-019331:0 · 2 Nov 2021
€23,031 2,152 shares @ €10.7022 0.017% mcap 12.7% of flow
Common Stock
SEC:0001567619-21-016145 · 17 Aug 2021
€23,031 2,152 shares @ €10.7022 0.028% mcap 6.3% of flow
Common Stock
SEC:0001567619-21-016145:0 · 17 Aug 2021
€61,704 5,184 shares @ €11.9028 100.0% of flow
Common Stock
SEC:0001209191-21-034428 · 18 May 2021
€61,704 5,184 shares @ €11.9028 0.076% mcap 16.8% of flow
Common Stock
SEC:0001209191-21-034428:0 · 18 May 2021
About Dupont Jakob Jakob Dupont is an executive at Atara Biotherapeutics, Inc.